New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...

In his testimony this week, Kennedy claimed that infectious diseases receive far more federal funding than chronic diseases.

Participants with metabolic syndrome who received 1,700 mg metformin daily with or without a Mediterranean diet intervention ...

For days, as the eight-year-old lay dying from diabetes, more than a dozen adults — her mother and father among them — prayed ...

Helping kids with obesity drop pounds can have a huge impact on their future health.When these children and teens los ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

ImmunoPrecise has outperformed the broader market in a spectacular fashion. As of now, IPA’s YTD performance stands at +81.64%, a staggering increase compared to the S&P 500’s YTD performance of just ...

People with type 2 diabetes had significantly fewer heart attacks, strokes, heart failures, and deaths from cardiovascular ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...